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Abstract
In this article, we consider models for time-to-event data obtained from experiments
in which stress levels are altered at intermediate stages during the observation period.
These experiments, known as step-stress tests, belong to the larger class of accelerated
tests used extensively in the reliability literature. The analysis of data from step-
stress tests largely relies on the popular cumulative exposure model. However, despite
its simple form, the utility of the model is limited, as it is assumed that the hazard
function of the underlying distribution is discontinuous at the points at which the
stress levels are changed, which may not be very reasonable. Due to this deficiency,
Kannan et al. [19] introduced the cumulative risk model, where the hazard function
is continuous. In this paper we propose a class of parametric models based on the
cumulative risk model assuming the underlying population contains long-term survivors
or ‘cured’ fraction. An EM algorithm to compute the maximum likelihood estimators
of the unknown parameters is proposed. This research is motivated by a study on
altitude decompression sickness. The performance of different parametric models will
be evaluated using data from this study.
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21 Introduction
In many applications in the physical, environmental, and biomedical sciences, the experi-
mental conditions may change during the exposure period. This research is motivated by a
study on altitude decompression sickness (DCS), a condition caused by a decrease in pressure
and lower oxygen levels at high altitudes. Mountaineers and travelers to high mountainous
regions frequently experience symptoms that include nausea, headaches, dizziness and fa-
tigue. Decompression sickness is also observed in deep-sea divers and mine workers. The
change in atmospheric pressure causes nitrogen to come out of solution and form bubbles
in tissues and the bloodstream. Symptoms of DCS range from mild joint pain and swelling
to dizziness, and in extreme cases death. To avoid/ decrease symptoms of decompression
sickness, mountaineers are advised to acclimatize to the altitude conditions and perform
gradual staged ascents. Deep-sea divers are provided with tables that specify the length of
time at each stage in the ascent from depth (decompression stops) to avoid the ”bends”. This
staged ascent can delay or eliminate the onset of symptoms by allowing nitrogen levels to
gradually dissipate. In the staged ascent, the experimental conditions (in this case, altitude)
are changed throughout the exposure period.
Greven et al. [12] described an experiment designed to examine the effects of water con-
tamination on fish, in particular on their swimming performance. The underlying hypothesis
was that fish exposed to toxins may exhibit a lower threshold for fatigue. Fatigue was in-
duced by increasing the stress, in this case the water velocity, at fixed time points during
the experiment.
The two examples described above are known as ”step-stress tests” in the reliability
literature. Step-stress tests belong to the larger class of accelerated tests that have been
extensively used in life-testing experiments. As products become more reliable, standard
3life-testing experiments often fail to provide adequate data on failure times, resulting in poor
estimates of reliability. Accelerated testing allows the researcher to overcome this problem
by subjecting the experimental units or items to higher than normal levels of stress. The
increase in stress reduces the time to failure by accelerating the degradation or deterioration
of the item. Using a model that relates the stress level to the failure distribution, properties
of the underlying failure distribution under normal operating conditions may be obtained.
In a standard step-stress experiment, all individuals or items are subject to an initial stress
level. The stress is gradually increased at pre-specified times during the experiment. The
stress factor may refer to the dose of a drug, incline/speed of a treadmill, temperature,
voltage, or pressure.
The most commonly used model for step-stress experiments is the cumulative exposure
model (CEM) introduced by Sedyakin [26]. The CEM and its variants have been studied
by a number of authors including Bai et al. [1], Balakrishnan [2], Balakrishnan et al. [3],
Gouno and Balakrishnan [13], Nelson [24, 25], Xiong [31], Xiong and Milliken [32], Khamis
and Higgins [22], Ismail [15], Kateri and Kamps [21] and Sha and Pan [29]. The formulation
of the CEM provides a relationship between the lifetime distribution of an experimental unit
at one stress level and the life-time distribution of the unit at a second stress level. As a
consequence of this assumption, the underlying hazard function is discontinuous at the time
point at which the stress level changes. This implies that the effect of a change in stress
level is instantaneous, which may not be realistic in practice.
Kannan et al. [17] proposed a new simple step-stress model assuming that there is a
latency or lag period δ before the effect of the change in stress level is observed. The
cumulative risk model (CRM), proposed by the authors, assumes that the hazard function
for the step stress experiment is continuous. The CEM and the time transformed Khamis
and Higgins [22] model may be obtained as limiting cases of the CRM. Kannan et al. [17]
4developed maximum likelihood and least squares estimators for the parameters of the CRM
assuming exponential lifetime distributions at the two stress levels. Beltrami [4] extended the
CRM to account for competing causes of failure assuming exponential and Weibull lifetime
distributions.
In recent years, the development of new drugs and treatment regimens has resulted in
patients living longer with certain diseases. In some cases, patients show no recurrence of
a disease, i.e are viewed as being permanently cured. These patients are referred to as
”cured” or long term survivors, while the remaining patients are referred to as ”susceptible”.
Traditional parametric survival models such as Weibull or Gamma do not account for the
probability of cure. Although subtle, it is important to distinguish between the concepts
of censoring and cure. Note that censoring refers to a subject who does not fail within the
monitoring time window of a particular item, where as cure refers to one who will not fail
within any reasonable time window. Clearly, the later is an abstraction, as we never observe
a cure due to a finite monitoring time. Still estimating the probability of such an outcome is
a important issue, see for example Tsodikov [30]. In the context of reliability or life-testing
applications, cure refers to items that are resistant and not affected by the stress factor. It
can happen even in a step-stress experiment also. For example, in the DCS study it has
been observed, see for example Kannan et al. [18], that even in the increased stress level
some of the experimental units are immune to the stress factors and they do not fail at the
higher stress level. They can be treated as the long term survivors.
The goal of this article is to develop a cumulative risk model assuming the underlying
population includes both ‘cured’ and susceptible individuals. We consider different paramet-
ric distributions to model the lifetimes of susceptible individuals. In Section 2, we define
the generalized cumulative risk model and discuss three special cases. In Section 3, using
the standard mixture model formulation, the generalized CRM is adapted to include a cured
5fraction. The probability of being cured is modeled as a function of covariates using a lo-
gistic link. Section 4 describes an EM algorithm for obtaining the MLEs of the parameters
and associated likelihood ratio tests. In Section 5, we fit different parametric models to the
data on altitude decompression sickness and evaluate the goodness of fit of these models.
Conclusions and future research directions are discussed in Section 6.
2 Generalized Cumulative Risk Model
Consider a life-testing experiment wherein the stress is changed only once during the exposure
duration. We assume that all n individuals or items under study are exposed to an initial
stress level x1. The items are continuously monitored, and at some pre-specified time τ1, the
stress level is changed (increased) to x2. We assume that there is a latency period δ before
the effects of the increased stress are observed.
We assume that the hazard function is continuous for all t > 0 and is increasing in
the interval [τ1, τ2], where τ2 = τ1 + δ. The piecewise hazard function for the Generalized
Cumulative Risk Model has the following form;
h0(t) =


h01(t) if 0 < t ≤ τ1
a+ bt if τ1 < t < τ2
h03(t) if τ2 ≤ t <∞
. (1)
Here h01(t) > 0 and h03(t) > 0 are continuous functions for t > 0, and
∫
∞
0
h0(t)dt =∞. (2)
The parameters a and b are such that the hazard function h0(t) is a continuous function for
t > 0. Therefore, a and b satisfy the following conditions:
a+ bτ1 = h01(τ1), (3)
a+ bτ2 = h03(τ2). (4)
6Note that, although for mathematical tractability, we assume the hazard function to be
linear in the interval [τ1, τ2], other smooth functions may be considered.
The generalized cumulative risk model, as defined through the hazard function (1), is
an extension of the cumulative risk model proposed by Kannan et al. [17]. The authors
considered the case when h01 = λ1 and h03(t) = λ2, i.e. exponential distributions with
different scale parameters.
When τ2 ↓ τ1 = τ (say), then (1) takes the form
h0(t) =


h01(t) if 0 < t ≤ τ
h03(t) if τ < t <∞.
(5)
Equation (5) is the hazard function for the cumulative exposure model in the case of ex-
ponential hazards (see Balakrishnan [2] or Kateri and Balakrishnan [20]), and the hazard
function of the model proposed by Khamis and Higgins [22] in the case of Weibull hazards,
when the two shape parameters are equal. It can also be observed as an generalization of
the tampered failure rate (TFR) model of Bhattacharyya and Soejoeti (1989). In the TFR
model h01(t)/h03(t) is a constant.
From (1), we obtain the cumulative hazard function as
H0(t) =


H01(t) if 0 < t ≤ τ1
H02(t) if τ1 < t < τ2
H03(t) if τ2 ≤ t <∞
, (6)
where
H01(t) =
∫ t
0
h01(u)du
H02(t) = H01(τ1) + a(t− τ1) +
b
2
(t2 − τ 21 )
H03(t) = H02(τ2) +
∫ t
τ2
h03(u)du.
7Therefore, the survival function is given by
S0(t) =


e−H01(t) if 0 < t ≤ τ1
e−H02(t) if τ1 < t < τ2
e−H03(t) if τ2 ≤ t <∞.
(7)
Note that due to the condition (2), (7) is a proper survival function. The associated proba-
bility density function (PDF) is
f0(t) =


f01(t) if 0 < t ≤ τ1
f02(t) if τ1 < t < τ2
f03(t) if τ2 ≤ t <∞,
(8)
where
f01(t) = h01(t) e
−H01(t), f02(t) = (a+ bt) e
−H02(t), f03(t) = h03(t) e
−H03(t). (9)
2.1 Special Cases
In this subsection, we describe three special cases of the generalized cumulative risk model.
Weibull Model: The Weibull distribution is one of the most widely used parametric
distribution in the survival analysis and reliability literature to analyze lifetime data. The
PDF of a two-parameter Weibull distribution has the following form:
f(t) = αλtα−1e−λt
α
; x > 0. (10)
Here α > 0 and λ > 0 are the shape and scale parameters, respectively.
Therefore, we have
h01(t) = α1λ1t
α1−1, h03(t) = α2λ2t
α2−1 (11)
8and
H01(t) = λ1t
α1 ,
H02(t) = λ1τ
α1
1 + a(t− τ1) +
b
2
(t2 − τ 21 )
H03(t) = λ1τ
α1
1 + a(τ2 − τ1) +
b
2
(τ 22 − τ
2
1 ) + (λ2τ
α2
2 − λ2t
α2).
Linear Failure Rate Distribution: The probability density function of a two-parameter
linear failure rate distribution for α > 0 and λ > 0, is given by
f(t) = (α + λt)e−αt−
λt
2
2 . (12)
In this case,
h01(t) = α1 + λ1t, h03(t) = α2 + λ2t (13)
and
H01(t) = α1t +
λ1t
2
2
,
H02(t) = α1τ1 +
λ1τ
2
1
2
+ a(t− τ1) +
b
2
(t2 − τ 21 )
H03(t) = α1τ1 +
λ1τ
2
1
2
+ a(τ2 − τ1) +
b
2
(τ 22 − τ
2
1 ) + α2(t− τ2) +
λ2
2
(t2 − τ 22 ).
Generalized Exponential Distribution: This lifetime model was introduced by Gupta
and Kundu [14] as an alternative to the gamma and Weibull distributions. The two-
parameter generalized exponential distribution has the following PDF:
f(t) = αλe−λt(1− e−λt)α−1; t > 0, (14)
where α > 0 and λ > 0 are the shape and scale parameters, respectively.
In this case
h01(t) =
α1λ1e
−λ1t(1− e−λ1t)α1−1
1− (1− e−λ1t)α1
, h03(t) =
α2λ2e
−λ2t(1− e−λ2t)α2−1
1− (1− e−λ2t)α2
(15)
9and
H01(t) = − ln
(
1− (1− e−λ1t)α1
)
,
H02(t) = − ln
(
1− (1− e−λ1τ1)α1
)
+ a(t− τ1) +
b
2
(t2 − τ 21 )
H03(t) = − ln
(
1− (1− e−λ1τ1)α1
)
+ a(τ2 − τ1) +
b
2
(τ 22 − τ
2
1 )
− ln
(
1− (1− e−λ2t)α2
)
− ln
(
1− (1− e−λ2τ2)α2
)
.
For all three cases, let Θ = (α1, α2, λ1, λ2) denote the parameter vector.
3 CRM with Long-Term Survivors
Extensive work has been done in formulating parametric and non-parametric survival models
incorporating a cured fraction, a non-zero tail probability of the survival function, starting
with the seminal paper by Boag [6], who proposed a two component mixture model to analyze
breast cancer data. The population of interest may be regarded as a mixture of cured and
susceptible individuals/ items. In this model, the survival function for the entire population
can be written as
P (T > t) = Sp(t) = pi + (1− pi)S(t),
where pi = Sp(+∞) is the ‘cured fraction’, and S(t) with S(+∞) = 0 is the proper survival
function for the ‘non-cured’ or the susceptible population. Since, then there has been exten-
sive research on the cure rate model, primarily in the survival analysis literature. Interested
readers may refer to the classical book by Maller and Zhou [23] or Yu et al. [33], Cancho
and Bolfarine [8], Chen et al. [10], Gamel et al. [11], Kannan et al. [19], and the references
cited therein.
The cumulative risk model can be extended to incorporate the cured fraction that rep-
resents individuals/items resistant to the stress factors. We assume that the susceptible
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population has a survival function S0(·) as defined in (7). The probability that an individual
is cured is assumed to depend on a set of s covariates z1, . . . , zs. Let z = (1, z1, . . . , zs). For
each individual under study with covariate vector z, we define an indicator random variable
∆(z), with ∆(z) = 1, when the subject is susceptible, and ∆(z) = 0, when the subject is
cured. It is assumed that
P (∆(z) = 0) = p(β, z) =
eβ
′
z
1 + eβ
′
z
and P (∆(z) = 1) = 1− p(β, z) =
1
1 + eβ
′
z
.
Here β is an s + 1 dimensional vector of coefficients and β0 represents the intercept term.
Let S(t;Θ,β, z) denote the survival function of an individual with covariate vector z. We
have
S(t;Θ,β, z) = p(β, z) + (1− p(β, z))S0(t;Θ), (16)
where S0(t;Θ) has the form of the cumulative risk model defined in (7).
It may be noted that we have linked the covariates only with the cure fraction and not
with the survival function S0(t;Θ). It may be argued that would provide more general
model. Although, it may be true but it raises some questions regarding choosing the proper
covariates for two different purposes, and their identifiability issues, see also Kannan et al.
[19]. Due to which it has been avoided.
4 Statistical Inference
4.1 Maximum Likelihood Estimation
In this section, we propose an EM algorithm to compute the maximum likelihood estimators
(MLEs) of the unknown parameters, namely, Θ and β. At the initial stage, we assume that
δ, or equivalently, τ2 = τ1 + δ is known. We will then describe a procedure to estimate δ.
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The observed failure times from the step-stress experiment are denoted by
0 < t1 < · · · < tn1 < τ1 < tn1+1 < · · · < tn1+n2 < τ2 < tn1+n2+1 < · · · ≤ tn1+n2+n3 . (17)
Here m = n1 + n2 + n3 represents the total number of failures observed. The remaining
observations
tn1+n2+n3+1 < . . . < tn1+n2+n3+n4 , (18)
where n4 = n − m, are censored. With each failure/censor time ti, we have an associated
covariate vector zi.
Let I1 = {1, · · · , n1}, I2 = {n1 + 1, · · · , n1 + n2}, I3 = {n1 + n2 + 1, · · · , n1 + n2 + n3}
and I4 = {n1 + n2 + n3 + 1, · · · , n1 + n2 + n3 + n4}. Here I4 denotes the set of censored
observations. Based on the observations {(ti, zi); i = 1, . . . , n}, the log-likelihood function
can be written as
l(Θ,β) = l1(Θ,β) + l2(Θ,β), (19)
where
l1(Θ,β) =
∑
i∈I1∪I2∪I3
ln(1− p(β, zi)) +
∑
i∈I1
ln f01(ti;Θ) +
∑
i∈I2
ln f02(ti;Θ) +
∑
i∈I3
ln f03(ti;Θ),
and
l2(Θ,β) =
∑
i∈I4
ln {p(β, zi) + (1− p(β, zi))S0(ti;Θ))} .
The maximum likelihood estimators of Θ and β can be obtained by maximizing the log-
likelihood function (19), and involves a (4+(s+1))-dimensional optimization problem, where
s denotes the number of covariates.
The MLEs may also be obtained by treating the problem as a missing data problem
and using the EM algorithm. For an individual with covariate vector z in I1 ∪ I2 ∪ I3,
the associated random variable ∆(z) takes the value 1. For an individual in I4, ∆(z) is
unobserved. Therefore, for these n4 observations, the associated ∆(z) values are treated as
missing.
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At the k − th stage of the EM algorithm, let Θ(k) and β(k) denote the estimates of the
parametersΘ and β, respectively. We then compute the pseudo log-likelihood function based
on the missing observations (’E’-step). For a censored time t, two partially complete ’pseudo
observation’ of the form (t, w1(t|Θ
(k),β(k), z)) and (t, w2(t|Θ
(k),β(k), z)) are constructed.
Here, w1(t|Θ
(k),β(k), z) and w2(t|Θ
(k),β(k), z) denote the conditional probabilities that the
individual with covariate z belongs to the cure and susceptible group, respectively, given
that the individual has survived till time t. We have
w1(t|Θ
(k),β(k), z) = P (∆(z) = 0|T > t,Θ(k))
and
w2(t|Θ
(k),β(k), z) = P (∆(z) = 1|T > t,Θ(k)).
We have
w1(t|Θ
(k),β(k), z) = P (∆(z) = 0|T > t,Θ(k),β(k))
=
P (T > t|∆(z) = 0,Θ(k),β(k))× P (∆(z) = 0|β(k))
P (T > t|Θ(k),β(k))
=
p(β(k), z)
p(β(k), z) + (1− p(β(k), z))S0(t|Θ
(k))
,
and
w2(t|Θ
(k),β(k), z) = P (∆(z) = 1|T > t,Θ(k),β(k))
=
P (T > t|∆(z) = 1,Θ(k),β(k))× P (∆(z) = 1|β(k))
P (T > t|Θ(k),β(k))
=
(1− p(β(k), z))S0(t|Θ
(k))
p(β(k), z) + (1− p(β(k), z))S0(t|Θ
(k))
.
Therefore, the ’pseudo log-likelihood’ function, Lpseudo(Θ,β) based on the missing obser-
vation is given by
lpseudo(Θ,β|Θ
(k),β(k)) = l1(Θ,β)
13
+
∑
i∈I4
{
w1(ti|Θ
(k),β(k)) ln p(β, zi)
+ w2(ti|Θ
(k),β(k)) ln [(1− p(β, zi))S0(ti|Θ)]
}
=
∑
i∈I1∪I2∪I3
ln(1− p(β, zi)) +
∑
i∈I4
w1(ti|Θ
(k),β(k)) ln p(β, zi)
+
∑
i∈I4
w2(ti|Θ
(k),β(k)) ln(1− p(β, zi))
+
∑
i∈I1
ln f01(ti|Θ) +
∑
i∈I2
ln f02(ti|Θ)
+
∑
i∈I3
ln f03(ti|Θ) +
∑
i∈I4
w2(ti|Θ
(k),β(k)) lnS0(ti|Θ)
= g1(β|Θ
(k),β(k)) + g2(Θ|Θ
(k)) (say), (20)
where
g1(β|Θ
(k),β(k)) =
∑
i∈I1∪I2∪I3
ln(1− p(β, zi)) +
∑
i∈I4
w1(ti|Θ
(k),β(k)) ln p(β, zi)
+
∑
i∈I4
w2(ti|Θ
(k),β(k)) ln(1− p(β, zi)), (21)
and
g2(Θ|Θ
(k)) = g3(Θ) +
∑
i∈I4
w2(ti|Θ
(k),β(k)) lnS0(ti|Θ). (22)
Here
g3(Θ) =
∑
i∈I1
ln f01(ti|Θ) +
∑
i∈I2
ln f02(ti|Θ) +
∑
i∈I3
ln f03(ti|Θ). (23)
The ’M’-step of the EM algorithm involves maximization of lpseudo(Θ|Θ
(k)) with respect to
the unknown parameters.
Assuming a model with no covariates, and denoting p(β, z) = p, the function (21) reduces
to
g1(p|Θ
(k), p(k)) = m ln(1− p) + ln p
∑
i∈I4
w1(ti|Θ
(k), p(k)) + ln(1− p)
∑
i∈I4
w2(ti|Θ
(k), p(k)), (24)
where
w1(ti|Θ
(k), p(k)) =
p(k)
p(k) + (1− p(k))S0(ti|Θ
(k))
(25)
14
and
w2(ti|Θ
(k), p(k)) =
(1− p(k))S0(ti|Θ
(k))
p(k) + (1− p(k))S0(ti|Θ
(k))
. (26)
Therefore
p(k+1) =
∑
i∈I4
w1(ti|Θ
(k), p(k))
n
. (27)
If the model includes covariates, a Newton-Raphson type method or other optimization
techniques may be used to maximize the functions g1(β|Θ
(k),β(k)) and g2(Θ|Θ
(k)).
So far we have assumed that δ is known. Since in practice δ is unknown we estimate δ by
maximizing the profile likelihood function with respect to δ. Since it cannot be done analyt-
ically we have suggested to use grid search method for this purpose. For each δ we compute
the MLEs of the unknown parameters as suggested above and obtain the corresponding
likelihood value, and then choose that δ for which the likelihood value is maximum. The
detailed implementation procedure will be explained in the Data Analysis section.
4.2 Testing of Hypothesis
In this section, we describe three hypotheses of interest and derive the corresponding like-
lihood ratio tests. In all the cases the exact tests are not available, hence, we rely on the
asymptotic tests. Since the sample size is not very small, it is well known that the asymptotic
tests work reasonably well.
Problem 1:
H01 : α1 = α2 vs. H11 : α1 6= α2. (28)
The hypothesis tests the equality of the shape parameters of the corresponding lifetime
distributions at the two different stress levels. Under the null hypothesis, the maximization
of g2(Θ|Θ
(k)) involves a three-dimensional optimization. Letting l01 and l11 denote the
maximized log-likelihood values under the null and alternative hypothesis, respectively, we
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have
−2(l01 − l11) ∼ χ
2
1. (29)
Problem 2:
H02 : α1 = α2 = 1 vs. H12 : α1 = α2 6= 1. (30)
The null hypothesis states that the lifetime distributions at the two different stress levels
are exponential. Under the null hypothesis, the maximization of g2(Θ|Θ
(k)) involves a two-
dimensional optimization. Letting l02 and l12 (= l11) denote the maximized log-likelihood
values under the null and alternative hypothesis, respectively, we have
−2(l02 − l12) ∼ χ
2
1. (31)
Problem 3:
H03 : β1 = β1 = . . . = βs = 0 vs. H13 : At least one of them is not 0 (32)
This is a test of the significance of the covariates. In the EM algorithm, the ’M’-step that
involves the maximization of g1(p|Θ
(k), p(k)) can be performed explicitly. From the likelihood
ratio test, it follows that
−2(l03 − l13) ∼ χ
2
s, (33)
where l03 and l13 denote the maximized log-likelihood values under the null and alternative
hypothesis, respectively.
Problem 4:
H04 : p = 0 vs. H14 : p > 0. (34)
This test assesses whether or not the underlying population has a cure fraction. Since 0 is a
boundary point of p, using Theorem 3 of Self and Liang [27], it follows that
−2(l04 − l14) ∼
1
2
+
1
2
χ21. (35)
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Here l04 and l14 denote the maximized log-likelihood values under the null and alternative
hypothesis, respectively. It may be mentioned that in this case l14 = l03.
5 Data Analysis and Simulation Experiments
5.1 Data Analysis
The motivation for this research comes from a study on altitude decompression sickness con-
ducted by the Air Force Research Laboratory (AFRL). In the study, human subjects were
exposed to simulated altitude in a hypobaric chamber. Subjects were exposed to different
altitudes, varying denitrogenation times, exposure duration, different breathing gas mixtures
during the exposure, and levels of exercise as determined by the flight protocol. During the
exposure, subjects were constantly monitored for symptoms of DCS. If a subject exhibited
any of the symptoms associated with DCS, the experiment was terminated and the sub-
ject repressurized to ground level. Subjects who did not exhibit any symptoms during the
exposure period are assumed to be censored.
During exposure to altitude, the gas exchange processes in the tissues are unable to expel
the excess nitrogen causing supersaturation. These gases which come out of solution when
tissues are sufficiently supersaturated collect as bubbles in the tissue. To delay the onset of
bubbles, researchers suggest either a staged decompression to altitude or prebreathing pure
oxygen prior to exposure to allow nitrogen diffusion through desaturation.
The data that we consider here comes from one of the flight profiles that involved a staged
ascent. 40 subjects were placed in the hypobaric chamber and exposed to an initial altitude
of 18,000 feet. After four hours (240 minutes), the altitude was increased to 35,000 feet and
the experiment continued for another three hours. In the first four hours of the exposure,
prior to the increase in altitude, 7 subjects reported DCS symptoms. At the end of the study,
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a total of 31 subjects reported DCS. The remaining 9 subjects were asymptomatic at the end
of the study, i.e. they do not show any symptoms of DCS. In the AFRL study, researchers
noted that there were several individuals who remained asymptomatic regardless of the
exposure duration and the final altitude. These individuals represent the cure population,
and researchers were interested in determining the characteristics that caused immunity.
The staged ascent profile is an example of a simple step-stress experiment and the presence
of a cure population makes the dataset ideal for the proposed model.
In the experiment, we have τ1 = 240 but the value of τ2 is unknown. We fit a cumulative
risk model to the data and estimate the unknown parameters for fixed τ2, assuming it to
be known. We vary the value of τ2 and employ a discrete optimization with a grid size of 5
minutes to find the value at which the likelihood is maximum.
The MLEs of the parameters of the cumulative risk model assuming Weibull, linear
failure rate (LFR) and generalized exponential (GE) hazards, their associated standard er-
rors (within parentheses), the corresponding maximized log-likelihood (MLL) values, the
Kolmogorov-Smirnov (K-S) distances between the empirical and fitted distributions, and
the p values for the K-S test are presented in Table 1.
Table 1: Parameter Estimates for the Models without Covariates.
Model α1 α2 λ1 λ2 p LL K-S p-value
Weibull 2.4972 1.5390 0.2341 0.9762 0.1820 -38.7093 0.0502 0.7519
(0.4213) (0.2587) (0.0378) (0.1175) (0.0298) – – –
LFR 0.0985 6.8254 0.0102 1.0915 0.2214 -41.1311 0.0949 0.2114
(0.0118) (1.2319) (0.0008) (0.2478) (0.0215) – – –
GE 5.0066 2.6427 1.3461 3.6877 0.1589 -39.6485 0.0589 0.6998
(0.9567) (0.4565) (0.3534) (0.7567) (0.0198) – – –
KH 1.2454 1.9290 0.2003 0.7446 0.1975 -39.0482 0.1007 0.1723
(0.1775) (0.3318) (0.0397) (0.1114) (0.0298) – – –
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For comparison purposes, we also fit the Khamis and Higgins [22] model with a cure
fraction. The Khamis and Higgins [22] model with Weibull hazards is a special case of the
cumulative risk model with δ = 0, i.e. τ1 = τ2
If we examine the maximized log-likelihood values and the K-S distances, it is clear that
the Weibull model provides the best fit. The Kaplan-Meier estimator of the survival function
and the survival function based on the Weibull model are provided in Figure 1. The two
curves are very close, indicating the Weibull model is indeed a good fit for the data. Using a
grid search, the estimate of τ2 was found to be 350 minutes. This implies a lag of 110 minutes
(almost 2 hours) before the effects of the increased altitude are observed. The cumulative
hazard function with the estimated value of τ2 is provided in Figure 2. We also obtain an
estimate of the cure fraction p. For the Weibull model, we estimate 18% of the population
to be asymptomatic.
We can test whether or not the population has a cure fraction by using the procedures
outlined in Section 4.2. Under the null hypothesis H04, the MLEs of the unknown parameters
and MLL value are
α̂1 = 1.9685, α̂2 = 1.8170, λ̂1 = 0.1539, λ̂2 = 1.0582, MLL = −41.2654.
The value of the test statistic is −2(−41.2654+38.7093) = 5.3122. Using the result (35), the
p-value is 0.0019, leading to rejection of the null hypothesis. This indicates the population
has a cure fraction.
In addition to the event times, researchers also collected covariate information on study
participants. For each subject, we have their age (in years), height (in cms), weight (in lbs),
body fat percentage (BF) and maximal oxygen uptake (V O2 max in liter/min). Since the
variability in the height and weight measurements was small, we only considered age, body
fat and V O2 max in the model. In Table 2, we provide information about the minimum
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Figure 1: Kaplan-Meier estimator and the estimated survival function based on the Weibull
model. Here time is measued in mins.
(min), maximum (max), median (Q2), first quartile (Q1) and third quartile (Q3) of the
covariates.
Table 2: Summary statistics of the covariates.
Cov. min max Q1 Q2 Q3
Body fat 5.9 29.9 14.6 17.1 21.1
V O2 max 1.9 6 2.7 3.2 3.95
Age 21 43 27 34 37
Given that the Weibull model provided the best fit for the data without covariates, we
assume a Weibull model with covariate vector Z = (1, BF, V O2, Age). We assume that
there is a lag of 110 minutes (i.e. τ2 = 350). The function p(β, z) is as follows:
p(β, z) =
exp(β0 + β1 ∗ BF + β2 ∗ V O2 + β3 ∗ Age)
1 + exp(β0 + β1 ∗ BF + β2 ∗ V O2 + β3 ∗ Age)
.
We fit Weibull models with all possible subsets of covariates. The maximum likelihood
estimates of the unknown parameters and the associated standard errors (within parentheses)
for all the sub-models are provided in Table 3.
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Table 3: Parameter Estimates for the Weibull Model with Covariates.
Covariates α1 α2 λ1 λ2 β0 β1 β2 β3 MLL
z = (1,BF, V O2, Age) 2.6299 1.8450 0.2215 1.1348 -1.8124 -3.9196 3.6604 -0.2154 -31.3009
(0.4789) (0.2918) (0.0445) (0.2191) (0.5412) (1.1212) (1.1318) (0.0519) –
z = (1,BF, V O2) 2.6037 1.9657 0.2159 0.9892 -1.8503 -3.9707 3.4585 -33.3294
(0.4339) (0.2711) (0.0401) (0.1999) (0.4798) (1.1198) (1.1010) – –
z = (1,BF, Age) 2.5249 1.8836 0.2339 1.0436 -0.2281 -3.9895 -1.0607 -33.6776
(0.4412) (0.2798) (0.0466) (0.1814) (0.0445) (1.1253) – (0.0498) –
z = (1,V O2, Age) 2.5808 1.8008 0.2307 1.1334 -2.1468 – 3.9776 -1.7856 -34.2477
(0.4398) (0.2810) (0.0511) (0.1889) (0.5798) – (1.2156) (0.0610) –
z = (1, BF) 2.4368 1.9457 0.2269 1.0348 -0.6206 -3.9817 – – -34.0121
(0.4310) (0.2716) (0.0515) (0.1817) (0.2656) (1.1191) – – –
z = (1, V O2) 2.5491 1.7902 0.2228 1.1726 -2.6528 – 3.9823 – -34.5618
(0.4397) (0.2926) (0.0511) (0.1898) (0.6545) – (1.1871) – –
z = (1, Age) 2.6066 1.9207 0.2268 0.9736 -0.3374 – – -3.0710 -34.9897
(0.4365) (0.2710) (0.0516) (0.1912) (0.1151) – – (1.1097) –
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Figure 2: Cumulative hazard function of the Weibull model. Here time is measued in mins.
To test whether or not the covariates are significant, we use the procedure outlined for
Problem 3 in Section 4.2. The value of the test statistic is -2(31.3099 - 38.7093) = 14.7988,
with a p-value of 0.002. We reject the null hypothesis and conclude that the covariates
considered here are significant. As body fat or age increases, the probability of immunity
decreases, and as V O2 increases, the probability of immunity increases. These results are
consistent with the physiology of decompression sickness. Using the Weibull model, we
provided the predicted survival function at three different sets of covariates. (i) Low Risk
(B): BF = 5.9, V O2 = 6.0, Age = 21, (ii) Medium Risk (M): BF = 17.1, V O2 = 3.2, Age
= 34, (iii) High Risk (W) BF = 29.9, V O2 = 1.9, Age = 43, in Figure 3. We see that
the survival functions are quite close up to 240 minutes (the initial exposure level) but the
effects of the change in altitude is different for the three groups. The High Risk group has
the lowest proportion of cure individuals.
5.2 Simulation Experiments
In this section we perform some small simulation experiments mainly to see how the proposed
methods work for different sample sizes and for the above parametric and covariated set
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Figure 3: Predicted survival function at three different sets of covariates. Time is measued
in mins. Here ‘B’ denotes low risk, ‘M’ denots medium risk and ‘W’ denots high risk.
up. We have generated samples from the Weibull model with covariates with the following
parameters: α1 = 2.6, α2 = 1.8, λ1 = 0.22, λ2 = 1.14, β0 = -1.80, β1 = -4.0, β2 = 3.7, β3 =
-0.20. We have considered the lag-period δ = 100. We have chosen these parameters values
since they closely mimic the original data. We have taken diferent sample sizes namely 40,
80, 120, 160 and 200. Since in the original data set the BF varies bettwen 5.9 and 29.9,
we have chosen at random between these two values for a generated sample. Similarly,
we have generated at random VO2 between 1.9 and 6.0, and Age between 20 and 43. We
have calculated the MLEs and the associated mean squared errors (MSEs) based on 1000
replications. All the results are based on 20% of censored data. We have reported the average
estimates and the square root of the MSEs of all the estimates. It is observed that as sample
size increases the MSEs and biases decrease. In all the cases the EM algorithm stops within
35 iterations. It seems the proposed method works well in this particular set up.
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Table 4: MLEs for the Weibull Model with Covariates for Different Sample Sizes.
Sample Size α1 α2 λ1 λ2 β0 β1 β2 β3
n = 40 2.8411 2.1105 0.2541 1.1768 -2.6816 -6.1141 2.1786 -0.2576
(0.6723) (0.3871) (0.0671) (0.3928) (0.7129) (1.3154) (1.4116) (0.0723)
n = 80 2.7921 2.0156 0.2487 1.1523 -2.4225 -5.8791 2.6517 -0.2443
(0.3817) (0.2011) (0.0401) (0.1987) (0.3610) (0.6578) (0.7750) (0.0411)
n = 120 2.7015 1.9767 0.2365 1.1511 -2.1065 -4.7910 2.8917 -0.2312
(0.2218) (0.1254) (0.0251) (0.1310) (0.2454) (0.4516) (0.4519) (0.0218)
n = 160 2.6811 1.8917 0.2310 1.1487 -1.9167 -4.4578 3.2166 -0.2189
(0.2013) (0.1045) (0.0222) (0.0967) (0.1810) (0.3331) (0.3843) (0.0202)
n = 200 2.6115 1.8214 0.2242 1.1411 -1.8382 -4.2331 3.5714 -0.2067
(0.1319) (0.0798) (0.0156) (0.0861) (0.1452) (0.2512) (0.2815) (0.0114)
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6 Conclusions
In this article, we propose a new model for step stress experiments that includes a cure
fraction. The susceptible population has been modeled using three different parametric forms
of the generalized cumulative risk model, and the probability of being cured is treated as a
function of covariates. Different models are fit to data from a study on altitude decompression
sickness, that was the motivation for this research. The results show that the Weibull
cumulative risk model with a cure fraction provides an excellent fit to the data. Using the
model, we were able to determine the significant covariates, estimate the cure proportion,
and find an estimate of the lag period. The model is extremely flexible and can be easily
adapted to different distributions and censoring schemes.
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